BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37965748)

  • 1. 'Synthesis, antiviral activity, molecular docking, and molecular dynamics studies of ethoxy phthalimide pyrazole derivatives against Cytomegalovirus and Varicella-Zoster virus: potential consequences and strategies for developing new antiviral treatments'.
    Verma AK; Yadav V; Bhojiya AA; Upadhyay SK; Singh N; Pareek SS; Ashid M; Ahmed SF; Hossain MS
    J Biomol Struct Dyn; 2023 Nov; ():1-20. PubMed ID: 37965748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing the sensitivities of noncognate inhibitors to varicella zoster virus thymidine kinase: implications for postherpetic neuralgia therapy with existing agents.
    Yang L; Mo X; Yang H; Dai H; Tan F
    J Mol Model; 2014 Jul; 20(7):2321. PubMed ID: 24961898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and Ativiral Activity of 5-(Benzylthio)-4-carbamyl-1,2,3-triazoles Against Human Cytomegalovirus (CMV) and Varicella-zoster Virus (VZV).
    Wen YN; Zhang ZF; Liu NN; Andrei G; Snoeck R; Xiang YH; Schols D; Chen X; Zhang ZY; Zhang QS; Wu QP
    Med Chem; 2017; 13(5):453-464. PubMed ID: 28290250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of 6- or 8-substitution on the antiviral activity of 3-arylalkylthiomethylimidazo[1,2-a]pyridine against human cytomegalovirus (CMV) and varicella-zoster virus (VZV): part II.
    Véron JB; Allouchi H; Enguehard-Gueiffier C; Snoeck R; Andrei G; De Clercq E; Gueiffier A
    Bioorg Med Chem; 2008 Nov; 16(21):9536-45. PubMed ID: 18835175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy of varicella-zoster virus by a novel class of highly specific anti-VZV bicyclic pyrimidine nucleosides.
    Balzarini J; McGuigan C
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):287-95. PubMed ID: 12084470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, chemical characterization, biological evaluation, and docking study of new 1,3,4-oxadiazole homonucleoside analogs.
    El Mansouri AE; Maatallah M; Ait Benhassou H; Moumen A; Mehdi A; Snoeck R; Andrei G; Zahouily M; Lazrek HB
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(8):1088-1107. PubMed ID: 32397827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of 6 or 8-substitution on the antiviral activity of 3-phenethylthiomethylimidazo[1,2-a]pyridine against human cytomegalovirus (HCMV) and varicella-zoster virus (VZV).
    Véron JB; Enguehard-Gueiffier C; Snoeck R; Andrei G; De Clercq E; Gueiffier A
    Bioorg Med Chem; 2007 Nov; 15(22):7209-19. PubMed ID: 17869124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel potential inhibitors of varicella-zoster virus thymidine kinase from ethnopharmacologic relevant plants through an
    Kwofie SK; Annan DG; Adinortey CA; Boison D; Kwarko GB; Abban RA; Adinortey MB
    J Biomol Struct Dyn; 2022; 40(23):12932-12947. PubMed ID: 34533095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and molecular dynamics simulation studies of quinoline derivatives as protease inhibitors against SARS-CoV-2.
    Singh VK; Chaurasia H; Kumari P; Som A; Mishra R; Srivastava R; Naaz F; Singh A; Singh RK
    J Biomol Struct Dyn; 2022; 40(21):10519-10542. PubMed ID: 34253149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Silico Design and Experimental Validation of Novel Oxazole Derivatives Against Varicella zoster virus.
    Kovalishyn V; Severin O; Kachaeva M; Kobzar O; Keith KA; Harden EA; Hartline CB; James SH; Vovk A; Brovarets V
    Mol Biotechnol; 2024 Apr; 66(4):707-717. PubMed ID: 36709460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of novel VEGFR2-TK inhibitors by phthalimide pharmacophore based virtual screening, molecular docking, MD simulation and DFT.
    Matore BW; Roy PP; Singh J
    J Biomol Struct Dyn; 2023; 41(22):13056-13077. PubMed ID: 36775656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of ultra-deep sequencing for detection of varicella-zoster virus antiviral resistance mutations.
    Mercier-Darty M; Boutolleau D; Lepeule R; Rodriguez C; Burrel S
    Antiviral Res; 2018 Mar; 151():20-23. PubMed ID: 29337163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?
    Andrei G; De Clercq E; Snoeck R
    Antiviral Res; 2004 Mar; 61(3):181-7. PubMed ID: 15168799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationship of the affinity of 5-substituted uracil nucleoside analogues for varicella-zoster virus thymidine kinase and their activity against varicella-zoster virus.
    Ashida N; Watanabe Y; Miura S; Kano F; Sakata S; Yamaguchi T; Suzutani T; Machida H
    Antiviral Res; 1997 Aug; 35(3):167-75. PubMed ID: 9298756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antiherpesvirus activities of 5-alkyl-2-thiopyrimidine nucleoside analogues.
    Shigeta S; Mori S; Watanabe F; Takahashi K; Nagata T; Koike N; Wakayama T; Saneyoshi M
    Antivir Chem Chemother; 2002 Mar; 13(2):67-82. PubMed ID: 12238531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative activity of selected antiviral compounds against clinical isolates of varicella-zoster virus.
    Andrei G; Snoeck R; Reymen D; Liesnard C; Goubau P; Desmyter J; De Clercq E
    Eur J Clin Microbiol Infect Dis; 1995 Apr; 14(4):318-29. PubMed ID: 7649195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of phosphorylation pathways of antiherpesvirus nucleosides by varicella-zoster virus-specific enzymes.
    Koyano S; Suzutani T; Yoshida I; Azuma M
    Antimicrob Agents Chemother; 1996 Apr; 40(4):920-3. PubMed ID: 8849252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, Anti-Varicella-Zoster Virus and Anti-Cytomegalovirus Activity of 4,5-Disubstituted 1,2,3-(1H)-Triazoles.
    Yuan WY; Chen X; Liu NN; Wen YN; Yang B; Andrei G; Snoeck R; Xiang YH; Wu YW; Jiang Z; Schols D; Zhang ZY; Wu QP
    Med Chem; 2019; 15(7):801-812. PubMed ID: 30411688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current pharmacological approaches to the therapy of varicella zoster virus infections: a guide to treatment.
    Snoeck R; Andrei G; De Clercq E
    Drugs; 1999 Feb; 57(2):187-206. PubMed ID: 10188760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, antiviral, cytotoxic and cytostatic evaluation of
    Rygielska-Tokarska D; Andrei G; Schols D; Snoeck R; Głowacka IE
    Monatsh Chem; 2016; 147(6):1081-1090. PubMed ID: 32214481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.